Douglas M. Fambrough, III
2020
Compensation breakdown
Non-Equity Incentive Plan | $345,000 |
---|---|
Option Awards | $3,880,000 |
Salary | $575,000 |
Stock Awards | $1,801,884 |
Other | $19,468 |
Total | $6,621,352 |
Fambrough received $3.9M in option awards, accounting for 59% of the total pay in 2020.
Fambrough also received $345K in non-equity incentive plan, $575K in salary, $1.8M in stock awards and $19.5K in other compensation.
Rankings
In 2020, Douglas M. Fambrough, III's compensation ranked 1,516th out of 13,090 executives tracked by ExecPay. In other words, Fambrough earned more than 88.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,516 out of 13,090 | 88th |
Division Manufacturing | 567 out of 5,624 | 90th |
Major group Chemicals And Allied Products | 205 out of 2,257 | 91st |
Industry group Drugs | 171 out of 1,957 | 91st |
Industry Pharmaceutical Preparations | 119 out of 1,462 | 92nd |
Pay ratio
Douglas M. Fambrough, III's Pay | $6,621,352 |
---|---|
Median Employee's Pay | $311,375 |
Pay Ratio | 21to 1 |
In 2020, the annual total compensation of Douglas M. Fambrough, III was $6,621,352.
The annual total compensation of the median employee at Dicerna Pharmaceuticals was $311,375.
The ratio of Douglas M. Fambrough, III's pay to the pay of median employee was therefore 21 to one.
Fambrough's colleagues
We found six more compensation records of executives who worked with Douglas M. Fambrough, III at Dicerna Pharmaceuticals in 2020.
2020
Ralf Rosskamp
Dicerna Pharmaceuticals
Chief Medical Officer
2020
John Green
Dicerna Pharmaceuticals
Chief Financial Officer
2020
Bob Brown
Dicerna Pharmaceuticals
Chief Scientific Officer
2020
James Weissman
Dicerna Pharmaceuticals
Chief Operating Officer
2020
Shreeram Aradhye
Dicerna Pharmaceuticals
Chief Medical Officer
2020
Douglas Pagán
Dicerna Pharmaceuticals